The Asia-Pacific flow cytometry market is witnessing robust growth, fueled by a booming demand for advanced diagnostics and research solutions. Key influences propelling this market expansion include an increasing prevalence of chronic diseases, growing allocation in healthcare infrastructure, and a surge in research activities in the biotechnology